Log in

TSE:APS - Aptose Biosciences Stock Price, Forecast & News

C$5.74
+0.73 (+14.57 %)
(As of 12/12/2019 08:17 AM ET)
Add
Today's Range
C$5.00
Now: C$5.74
C$5.75
50-Day Range
C$2.48
MA: C$3.26
C$5.39
52-Week Range
C$2.08
Now: C$5.74
C$5.75
Volume230,205 shs
Average Volume24,339 shs
Market CapitalizationC$318.50 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies. The company has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806, a non-covalent small molecule therapeutic agent, which is in preclinical stage for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia/mantle cell lymphoma. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+1-647-4799828

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$0.93 per share
Book ValueC$0.49 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$318.50 million
Next Earnings Date3/10/2020 (Estimated)
OptionableNot Optionable

Receive APS News and Ratings via Email

Sign-up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter.


Aptose Biosciences (TSE:APS) Frequently Asked Questions

What is Aptose Biosciences' stock symbol?

Aptose Biosciences trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APS."

When is Aptose Biosciences' next earnings date?

Aptose Biosciences is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Aptose Biosciences.

What price target have analysts set for APS?

2 brokerages have issued 1-year price objectives for Aptose Biosciences' shares. Their forecasts range from C$6.00 to C$6.00. On average, they anticipate Aptose Biosciences' share price to reach C$6.00 in the next twelve months. This suggests a possible upside of 4.5% from the stock's current price. View Analyst Price Targets for Aptose Biosciences.

What is the consensus analysts' recommendation for Aptose Biosciences?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aptose Biosciences in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aptose Biosciences.

Has Aptose Biosciences been receiving favorable news coverage?

Media headlines about APS stock have been trending negative this week, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Aptose Biosciences earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Aptose Biosciences.

What other stocks do shareholders of Aptose Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aptose Biosciences investors own include Aptose Biosciences (APTO), Aurinia Pharmaceuticals (AUPH), Advanced Micro Devices (AMD), NVIDIA (NVDA), Adobe (ADBE), Micron Technology (MU), Visa (V), Aurora Cannabis (ACB), Altagas (ALA) and Bank of Montreal (BMO).

Who are Aptose Biosciences' key executives?

Aptose Biosciences' management team includes the folowing people:
  • Dr. William G. Rice Ph.D., Chairman, Pres & CEO (Age 59)
  • Mr. Gregory K. Chow CPA, MBA, BA, Sr. VP, CFO & Principal Accounting Officer (Age 45)
  • Mr. Ernest Kitt B.S., M.S, VP of Devel. & Technical Operations
  • Dr. Stephen B. Howell, Chief Medical Officer (Age 73)
  • Mr. Peter Murray, Director of Clinical Devel.

How do I buy shares of Aptose Biosciences?

Shares of APS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Aptose Biosciences' stock price today?

One share of APS stock can currently be purchased for approximately C$5.74.

How big of a company is Aptose Biosciences?

Aptose Biosciences has a market capitalization of C$318.50 million. View Additional Information About Aptose Biosciences.

What is Aptose Biosciences' official website?

The official website for Aptose Biosciences is http://aptose.com/.

How can I contact Aptose Biosciences?

Aptose Biosciences' mailing address is 5955 Airport Rd Suite 228, MISSISSAUGA, ON L4V 1R9, Canada. The biotechnology company can be reached via phone at +1-647-4799828.


MarketBeat Community Rating for Aptose Biosciences (TSE APS)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  165 (Vote Outperform)
Underperform Votes:  132 (Vote Underperform)
Total Votes:  297
MarketBeat's community ratings are surveys of what our community members think about Aptose Biosciences and other stocks. Vote "Outperform" if you believe APS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel